Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Celadon Pharmaceuticals PLC has successfully raised £1.05 million by placing over 2.6 million new shares at a discounted price, with the intention of managing short-term cash requirements and working capital until December 2024. Amidst delayed funding from previous rounds and ongoing credit facility negotiations, the company maintains a cautious but hopeful outlook on its financial future, expecting to publish interim results soon. CEO James Short expresses gratitude for the support and confidence in the company’s long-term value, following a strategic collaboration announcement.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.
